The era of AI for Science (AI4S) has arrived. The field of life sciences has thus witnessed a profound paradigm shift, with traditional R&D paths that rely on trial-and-error and empirical accumulation being reshaped by a data-driven model centered on artificial intelligence. AI technology transforms massive, scattered, and complex biological information into verifiable and reproducible scientific laws, breaking through long-standing efficiency bottlenecks and structural reproducibility challenges in life science R&D.
Based on this transformation, AI for Life Sciences (AI4LS) is accelerating the construction of new scientific research infrastructure centered on data as a production factor. The system encompasses key technical modules such as high-throughput data collection, intelligent algorithm modeling, automated experimental verification, and knowledge graph construction, forming an innovative research ecosystem. Currently, AI4LS has demonstrated its empowering effects in multiple frontier fields such as drug R&D, research laboratories, genomics, and synthetic biology. It is foreseeable that AI4LS will continue to lead life sciences towards more efficient, precise, and predictable directions, becoming a key engine for promoting the high-quality development of the bioeconomy.
Frost & Sullivan (referred to as 'Frost & Sullivan') officially released the '2025 China AI4LS Industry Development Blue Book' (hereinafter referred to as the 'Blue Book') on November 3, 2025, comprehensively analyzing the full ecosystem of AI4LS from scientific research paradigm evolution, multi-dimensional driving systems to scenario application implementation, and systematically sorting out the technology matrix, business models, and future trends. Through in-depth exploration of high-potential tracks and core growth drivers, this Blue Book aims to provide forward-looking market insights and strategic decision-making references for relevant enterprises and investors.
